204319-69-7 Usage
General Description
[4-(trifluoromethyl)-1,3-thiazol-2-yl]methanol is a chemical compound with the molecular formula C6H5F3NOS. It is a thiazole derivative with a trifluoromethyl group attached to the thiazole ring. [4-(trifluoromethyl)-1,3-thiazol-2-yl]methanol is used in the synthesis of pharmaceutical agents, agrochemicals, and materials science applications. It can also act as a building block for the synthesis of various organic compounds. The trifluoromethyl group in this compound makes it useful for medicinal chemistry, as it can enhance the biological activity and metabolic stability of drugs. Additionally, the thiazole ring is a common structural motif in many biologically active natural products and pharmaceuticals. Overall, [4-(trifluoromethyl)-1,3-thiazol-2-yl]methanol is a versatile compound with potential applications in various fields of chemistry and biology.
Check Digit Verification of cas no
The CAS Registry Mumber 204319-69-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,4,3,1 and 9 respectively; the second part has 2 digits, 6 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 204319-69:
(8*2)+(7*0)+(6*4)+(5*3)+(4*1)+(3*9)+(2*6)+(1*9)=107
107 % 10 = 7
So 204319-69-7 is a valid CAS Registry Number.
204319-69-7Relevant articles and documents
LIVER X RECEPTORS (LXR) MODULATORS
-
Page/Page column 51-52, (2018/11/22)
The present invention relates to sulfonamide-, sulfinamide- or sulfonimidamide containing compounds which bind to the liver X receptor (LXRa and/or LXR?) and act preferably as inverse agonists of LXR.
OXADIAZOLE COMPOUNDS WHICH INHIBIT BETA-SECRETASE ACTIVITY AND METHODS OF USE THEREOF
-
Page/Page column 90, (2012/05/05)
The invention provides novel beta-secretase inhibitors and methods for their including methods of treating Alzheimer's disease.
BICYCLIC PYRIMIDIN-4-(3H)-ONES AND ANALOGUES AND DERIVATIVES THEREOF WHICH MODULATE THE FUNCTION OF THE VANILLOID-1 RECEPTOR (VR1)
-
Page/Page column 52, (2010/02/12)
Compounds of formula (I); which are useful as therapeutic compounds, particularly in the treatment of pain and other conditions ameliorated by the modulation of the function of the vanilloid-1 receptor (VR1).
